Compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S260100, C544S278000, C544S117000

Reexamination Certificate

active

06890923

ABSTRACT:
A compound of formulaor a pharmaceutically acceptable salt thereof, wherein R is —C(O)Ar1, —C(R4)(R5)Ar1or Ar3; R3represents a group X—R10or Ar2; X represents a bond or a group NR11; and R10represents C1-6alkyl, C2-6alkenyl or C2-6alkynyl, each of which may be optionally substituted by one or more substituents independently selected from carboxyl, hydroxyl, —C(O)—R12, C3-6cycloalkyl, morpholinyl, —NR13R14, —SR15, —OR16, phenyl and halophenyl, or R10represents a C3-6cycloalkylcarbonyl, —C(O)CH2CN, halophenylcarbonyl or trifluoromethylcarbonyl group. The compounds or compositions thereof are useful in the treatment or prophylaxis of autoimmune, inflammatory, proliferative and hyperproliferative diseases.

REFERENCES:
patent: 6180635 (2001-01-01), Cheshire et al.
patent: 20040014634 (2004-01-01), Bantick et al.
patent: 20040180873 (2004-09-01), Hanssen et al.
patent: 20040180907 (2004-09-01), Hanssen et al.
patent: 2363377 (2001-12-01), None
patent: WO 9854190 (1998-12-01), None
patent: WO 3011868 (2003-02-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3381410

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.